These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38175422)
1. Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy. Taira N; Kikawa Y; Iwamoto T; Miyoshi Y; Hara K; Yoshitomi S; Hikino H; Takahashi H; Takabatake D; Kubo S; Ikeda M; Doihara H; Shien T; Okuyama H; Tanabe Y; Hara F; Yamanouchi K; Hagiwara Y; Sawaki M Breast Cancer; 2024 Mar; 31(2):283-294. PubMed ID: 38175422 [TBL] [Abstract][Full Text] [Related]
2. A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy. Okuyama H; Takada F; Taira N; Nakamura S Breast Cancer; 2024 Sep; 31(5):787-797. PubMed ID: 38796818 [TBL] [Abstract][Full Text] [Related]
3. Who is more likely to adopt and comply with the electronic patient-reported outcome measure (ePROM) mobile application? A real-world study with cancer patients undergoing active treatment. Lee M; Kang D; Kim S; Lim J; Yoon J; Kim Y; Shim S; Kang E; Ahn JS; Cho J; Shin SY; Oh D Support Care Cancer; 2022 Jan; 30(1):659-668. PubMed ID: 34363495 [TBL] [Abstract][Full Text] [Related]
4. Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol. Kyte D; Bishop J; Brettell E; Calvert M; Cockwell P; Dutton M; Eddington H; Hadley G; Ives NJ; Jackson LJ; Stringer S; Valente M BMJ Open; 2018 Oct; 8(10):e026080. PubMed ID: 30373785 [TBL] [Abstract][Full Text] [Related]
5. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study. Kang D; Kim S; Kim H; Lee M; Kong SY; Chang YJ; Sim SH; Kim YJ; Cho J JMIR Public Health Surveill; 2023 Mar; 9():e44105. PubMed ID: 36884274 [TBL] [Abstract][Full Text] [Related]
6. Results of a pilot feasibility randomised controlled trial exploring the use of an electronic patient-reported outcome measure in the management of UK patients with advanced chronic kidney disease. Kyte D; Anderson N; Bishop J; Bissell A; Brettell E; Calvert M; Chadburn M; Cockwell P; Dutton M; Eddington H; Forster E; Hadley G; Ives NJ; Jackson LJ; O'Brien S; Price G; Sharpe K; Stringer S; Verdi R; Waters J; Wilcockson A BMJ Open; 2022 Mar; 12(3):e050610. PubMed ID: 35304391 [TBL] [Abstract][Full Text] [Related]
7. Assessing Patient-Reported Outcomes in Routine Cancer Clinical Care Using Electronic Administration and Telehealth Technologies: Realist Synthesis of Potential Mechanisms for Improving Health Outcomes. Govindaraj R; Agar M; Currow D; Luckett T J Med Internet Res; 2023 Nov; 25():e48483. PubMed ID: 38015606 [TBL] [Abstract][Full Text] [Related]
8. App-Controlled Treatment Monitoring and Support for Head and Neck Cancer Patients (APCOT): Protocol for a Prospective Randomized Controlled Trial. Sprave T; Zöller D; Stoian R; Rühle A; Kalckreuth T; Haehl E; Fahrner H; Binder H; Grosu AL; Heinemann F; Nicolay NH JMIR Res Protoc; 2020 Dec; 9(12):e21693. PubMed ID: 33295291 [TBL] [Abstract][Full Text] [Related]
9. Patient and Clinician Perspectives on Electronic Patient-Reported Outcome Measures in the Management of Advanced CKD: A Qualitative Study. Aiyegbusi OL; Kyte D; Cockwell P; Marshall T; Dutton M; Walmsley-Allen N; Slade A; McMullan C; Calvert M Am J Kidney Dis; 2019 Aug; 74(2):167-178. PubMed ID: 31003865 [TBL] [Abstract][Full Text] [Related]
11. Patients' experiences of engaging with electronic Patient Reported Outcome Measures (PROMs) after the completion of radiation therapy for breast cancer: a pilot service evaluation. Hughes J; Flood T J Med Radiat Sci; 2023 Dec; 70(4):424-435. PubMed ID: 37550951 [TBL] [Abstract][Full Text] [Related]
12. Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study. Zivanovic O; Chen LY; Vickers A; Straubhar A; Baser R; Veith M; Aiken N; Carter J; Curran K; Simon B; Mueller J; Jewell E; Chi DS; Sonoda Y; Abu-Rustum NR; Leitao MM Gynecol Oncol; 2020 Oct; 159(1):187-194. PubMed ID: 32718730 [TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
14. Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: A nested cohort within the PRO-TECT pragmatic trial (AFT-39). Mody GN; Stover AM; Wang M; King-Kallimanis BL; Jansen J; Henson S; Chung AE; Jonsson M; Bennett A; Smith AB; Wood WA; Deal A; Ginos B; Dueck AC; Schrag D; Basch E Lung Cancer; 2021 Dec; 162():1-8. PubMed ID: 34634754 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer. Suzuki Y; Iwamoto T; Uno M; Hatono M; Kajiwara Y; Takahashi Y; Kochi M; Shien T; Kikawa Y; Uemura Y; Hagiwara Y; Yamamoto S; Taira N; Doihara H; Toyooka S Breast Cancer; 2023 Sep; 30(5):856-868. PubMed ID: 37422608 [TBL] [Abstract][Full Text] [Related]
16. Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial. Basch E; Schrag D; Henson S; Jansen J; Ginos B; Stover AM; Carr P; Spears PA; Jonsson M; Deal AM; Bennett AV; Thanarajasingam G; Rogak LJ; Reeve BB; Snyder C; Bruner D; Cella D; Kottschade LA; Perlmutter J; Geoghegan C; Samuel-Ryals CA; Given B; Mazza GL; Miller R; Strasser JF; Zylla DM; Weiss A; Blinder VS; Dueck AC JAMA; 2022 Jun; 327(24):2413-2422. PubMed ID: 35661856 [TBL] [Abstract][Full Text] [Related]
17. PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients-study protocol for a randomised controlled trial. Karsten MM; Kühn F; Pross T; Blohmer JU; Hage AM; Fischer F; Rose M; Grittner U; Gebert P; Ferencz J; Pauler L; Breidenbach C; Kowalski C; Trials; 2021 Sep; 22(1):666. PubMed ID: 34583744 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study. Kikawa Y; Hatachi Y; Rumpold G; Tokiwa M; Takebe S; Ogata T; Satake H; Kato H; Tsuji A; Yasui H; Holzner B Breast Cancer; 2019 Mar; 26(2):255-259. PubMed ID: 30194662 [TBL] [Abstract][Full Text] [Related]
19. Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial. Basch E; Pugh SL; Dueck AC; Mitchell SA; Berk L; Fogh S; Rogak LJ; Gatewood M; Reeve BB; Mendoza TR; O'Mara AM; Denicoff AM; Minasian LM; Bennett AV; Setser A; Schrag D; Roof K; Moore JK; Gergel T; Stephans K; Rimner A; DeNittis A; Bruner DW Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):409-418. PubMed ID: 28463161 [TBL] [Abstract][Full Text] [Related]